24R,25-Dihydroxyvitamin D3 promotes the osteoblastic differentiation of human mesenchymal stem cells

Molecular Endocrinology

Volumn 28, Issue 5, 2014, Pages 644-658

  Curtis, Kevin M ^a,b   Aenlle, Kristina K ^a   Roos, Bernard A ^a,b   Howard, Guy A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CHOLESTANETRIOL 26 MONOOXYGENASE; COLECALCIFEROL; COLLAGEN 1A1; CYTOCHROME P450; CYTOCHROME P450 24A1; CYTOCHROME P450 27B1; CYTOCHROME P450 2R1; DEXAMETHASONE; GLUCOCORTICOID; OSTEOCALCIN; OXYGENASE; REACTIVE OXYGEN METABOLITE; SECALCIFEROL; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL;

ADOLESCENT; ADULT; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; ENDOCRINE SYSTEM; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MESENCHYMAL STEM CELL; MINERALIZATION; MOLECULAR BIOLOGY; OSTEOBLAST; PRIORITY JOURNAL; BONE MINERALIZATION; CELL CULTURE; DRUG EFFECTS; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; YOUNG ADULT;

24,25-DIHYDROXYVITAMIN D 3; 25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; CALCIFICATION, PHYSIOLOGIC; CALCITRIOL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHILD; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; REACTIVE OXYGEN SPECIES; YOUNG ADULT;

EID: 84899713486     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2013-1241     Document Type: Article

References (61)

1. van Leeuwen JP, van den Bemd GJ, van Driel M, Buurman CJ, Pols HA. 24, 25-Dihydroxyvitamin D3 and bone metabolism. Steroids. 2001; 66: 375-380.
2. Lambert PW, Stern PH, Avioli RC, Brackett NC, Turner RT, Greene A, et al. Evidence for extrarenal production of 1β, 25-dihydroxyvitamin D in man. J Clin Invest. 1982; 69: 722-725.
3. Briggs AD, Kuan V, Greiller CL, Maclaughlin BD, Ramachandran M, Harris T, et al. Longitudinal study of vitamin D metabolites after long bone fracture. J Bone Miner Res. 2013; 28: 1301-1307.
4. Kawakami M, Imawari M, Goodman DS. Quantitative studies of the interaction of cholecalciferol (vitamin D3) and its metabolites with different genetic variants of the serum binding protein for these sterols. Biochem J. 1979; 179: 413-423.
5. Jones G. Vitamin D analogs. Endocrinol Metab Clin North Am. 2010; 39: 447-472, table of contents.
6. Christakos S, Ajibade DV, Dhawan P, Fechner AJ, Mady LJ. Vitamin D: metabolism. Endocrinol Metab Clin North Am. 2010; 39: 243-253, table of contents.
7. LoPiccolo MC, Lim HW. Vitamin D in health and disease. Photodermatol Photoimmunol Photomed. 2010; 26: 224-229.
8. Norman AW, Bouillon R. Vitamin D nutritional policy needs a vision for the future. Exp Biol Med (Maywood). 2010; 235: 1034-1045.
9. Mehta B, Ramanathan M, Weinstock-Guttman B. Vitamin D and multiple sclerosis: can vitamin D prevent disease progression? Expert Rev Neurother. 2011; 11: 469-471.
10. Weinstock-Guttman B, Zivadinov R, Qu J, Cookfair D, Duan X, Bang E, et al. VitaminDmetabolites are associated with clinical and MRI outcomes in multiple sclerosis patients. J Neurol Neurosurg Psychiatry. 2011; 82: 189-195.
11. Seo EG, Norman AW. Three-fold induction of renal 25-hydroxyvitamin D3-24-hydroxylase activity and increased serum 24, 25-dihydroxyvitamin D3 levels are correlated with the healing process after chick tibial fracture. J Bone Miner Res. 1997; 12: 598-606.
12. Birkenhäger-Frenkel DH, Pols HA, Zeelenberg J, et al. Effects of 24R, 25-dihydroxyvitamin D3 in combination with 1β-hydroxyvitamin D3 in predialysis renal insufficiency: biochemistry and histomorphometry of cancellous bone. J Bone Miner Res. 1995; 10: 197-204.
13. D'Ippolito G, Schiller PC, Perez-Stable C, Balkan W, Roos BA, Howard GA. Cooperative actions of hepatocyte growth factor and 1, 25-dihydroxyvitamin D3 in osteoblastic differentiation of human vertebral bone marrow stromal cells. Bone. 2002; 31: 269-275.
14. Howard GA, Turner RT, Sherrard DJ, Baylink DJ. Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1, 25-dihydroxyvitamin D3 and 24, 25-dihydroxyvitamin D3. J Biol Chem. 1981; 256: 7738-7740.
15. Geng S, Zhou S, Glowacki J. Effects of 25-hydroxyvitamin D3 on proliferation and osteoblast differentiation of human marrow stromal cells require CYP27B1/1β-hydroxylase. J Bone Miner Res. 2011; 26: 1145-1153.
16. Zhou S, LeBoff MS, Glowacki J. Vitamin D metabolism and action in human bone marrow stromal cells. Endocrinology. 2010; 151: 14-22.
17. Dhawan P, Christakos S. Novel regulation of 25-hydroxyvitamin D3 24-hydroxylase (24(OH)ase) transcription by glucocorticoids: cooperative effects of the glucocorticoid receptor, C/EBPβ, and the vitamin D receptor in 24(OH)ase transcription. J Cell Biochem. 2010; 110: 1314-1323.
18. Hidalgo AA, Deeb KK, Pike JW, Johnson CS, Trump DL. Dexamethasone enhances 1β, 25-dihydroxyvitaminD3 effects by increasing vitamin D receptor transcription. J Biol Chem. 2011; 286: 36228-36237.
19. Hidalgo AA, Trump DL, Johnson CS. Glucocorticoid regulation of the vitamin D receptor. J Steroid Biochem Mol Biol. 2010; 121: 372-375.
20. Canalis E, Delany AM. Mechanisms of glucocorticoid action in bone. Ann NY Acad Sci. 2002; 966: 73-81.
21. De Nijs RN. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options. Minerva Med. 2008; 99: 23-43.
22. D'Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. Agerelated osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res. 1999; 14: 1115-1122.
23. Curtis KM, Gomez LA, Rios C, et al. EF1β and RPL13a represent normalization genes suitable for RT-qPCR analysis of bone marrow derived mesenchymal stem cells. BMC Mol Biol. 2010; 11: 61.
24. Linsley C, Wu B, Tawil B. The effect of fibrinogen, collagen type I, and fibronectin on mesenchymal stem cell growth and differentiation into osteoblasts. Tissue Eng Part A. 2013; 19: 1416-1423.
25. Beresford JN, Joyner CJ, Devlin C, Triffitt JT. The effects of dexamethasone and 1, 25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro. Arch Oral Biol. 1994; 39: 941-947.
26. van Driel M, Koedam M, Buurman CJ, et al. Evidence for auto/paracrine actions of vitamin D in bone: 1β-hydroxylase expression and activity in human bone cells. FASEB J. 2006; 20: 2417-2419.
27. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29: e45.
28. Studer D, Lischer S, Jochum W, Ehrbar M, Zenobi-Wong M, Maniura-Weber K. Ribosomal protein L13a as a reference gene for human bone marrow-derived mesenchymal stromal cells during expansion, adipo-, chondro-, and osteogenesis. Tissue Eng Part C Methods. 2012; 18: 761-771.
29. Stanford CM, Jacobson PA, Eanes ED, Lembke LA, Midura RJ. Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J Biol Chem. 1995; 270: 9420-9428.
30. Zehnder D, Bland R, Chana RS, et al. Synthesis of 1, 25-dihydroxyvitamin D3 by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol. 2002; 13: 621-629.
31. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000; 408: 239-247.
32. Grzelak A, Rychlik B, Bartosz G. Light-dependent generation of reactive oxygen species in cell culture media. Free Radic Biol Med. 2001; 30: 1418-1425.
33. Arai M, Shibata Y, Pugdee K, Abiko Y, Ogata Y. Effects of reactive oxygen species (ROS) on antioxidant system and osteoblastic differentiation in MC3T3-E1 cells. IUBMB Life. 2007; 59: 27-33.
34. Ornoy A, Goodwin D, Noff D, Edelstein S. 24, 25-Dihydroxyvitamin D is a metabolite of vitamin D essential for bone formation. Nature. 1978; 276: 517-519.
35. Norman AW, Henry HL, Malluche HH. 24R, 25-Dihydroxyvitamin D3 and 1β, 25-dihydroxyvitamin D3 are both indispensable for calcium and phosphorus homeostasis. Life Sci. 1980; 27: 229-237.
36. Seo EG, Einhorn TA, Norman AW. 24R, 25-Dihydroxyvitamin D3: an essential vitamin D3 metabolite for both normal bone integrity and healing of tibial fracture in chicks. Endocrinology. 1997; 138: 3864-3872.
37. Norman AW, Okamura WH, Bishop JE, Henry HL. Update on biological actions of 1β, 25(OH)2-vitamin D3 (rapid effects) and 24R, 25(OH)2-vitamin D3. Mol Cell Endocrinol. 2002; 197: 1-13.
38. Henry HL, Norman AW. Vitamin D: two dihydroxylated metabolites are required for normal chicken egg hatchability. Science. 1978; 201: 835-837.
39. Matsumoto T, Ezawa I, Morita K, Kawanobe Y, Ogata E. Effect of vitamin D metabolites on bone metabolism in a rat model of postmenopausal osteoporosis. J Nutr Sci Vitaminol (Tokyo). 1985; 31 Suppl: S61-5.
40. Endres B, Kato S, DeLuca HF. Metabolism of 1β, 25-dihydroxyvitamin D(3) in vitamin D receptor-ablated mice in vivo. Biochemistry. 2000; 39: 2123-2129.
41. Sömjen D, Sömjen GJ, Harell A, Mechanic GL, Binderman I. Partial characterization of a specific high affinity binding macromolecule for 24R, 25 dihydroxyvitamin D3 in differentiating skeletal mesenchyme. Biochem Biophys Res Commun. 1982; 106: 644-651.
42. Sömjen D, Sömjen GJ, Weisman Y, Binderman I. Evidence for 24, 25-dihydroxycholecalciferol receptors in long bones of newborn rats. Biochem J. 1982; 204: 31-36.
43. Kato A, Seo EG, Einhorn TA, Bishop JE, Norman AW. Studies on 24R, 25-dihydroxyvitamin D3: evidence for a nonnuclear membrane receptor in the chick tibial fracture-healing callus. Bone. 1998; 23: 141-146.
44. Seo EG, Kato A, Norman AW. Evidence for a 24R, 25(OH)2-vitamin D3 receptor/binding protein in a membrane fraction isolated from a chick tibial fracture-healing callus. Biochem Biophys Res Commun. 1996; 225: 203-208.
45. Pedrozo HA, Schwartz Z, Rimes S, et al. Physiological importance of the 1, 25(OH)2D3 membrane receptor and evidence for a membrane receptor specific for 24, 25(OH)2D3. J Bone Miner Res. 1999; 14: 856-867.
46. St-Arnaud R. CYP24A1-deficient mice as a tool to uncover a biological activity for vitamin D metabolites hydroxylated at position 24. J Steroid Biochem Mol Biol. 2010; 121: 254-256.
47. Larsson D, Nemere I, Aksnes L, Sundell K. Environmental salinity regulates receptor expression, cellular effects, and circulating levels of two antagonizing hormones, 1, 25-dihydroxyvitamin D3 and 24, 25-dihydroxyvitamin D3, in rainbow trout. Endocrinology. 2003; 144: 559-566.
48. van Driel M, Koedam M, Buurman CJ, et al. Evidence that both 1β, 25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization. J Cell Biochem. 2006; 99: 922-935.
49. Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology. 1994; 134: 277-286.
50. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem. 1997; 64: 295-312.
51. Alm JJ, Heino TJ, Hentunen TA, Väänänen HK, Aro HT. Transient 100 nM dexamethasone treatment reduces inter-and intraindividual variations in osteoblastic differentiation of bone marrowderived human mesenchymal stem cells. Tissue Eng Part C Methods. 2012; 18: 658-666.
52. Atkins GJ, Anderson PH, Findlay DM, et al. Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1β, 25-dihydroxyvitamin D3. Bone. 2007; 40: 1517-1528.
53. Matilainen JM, Malinen M, TurunenMM, Carlberg C, Väisänen S. The number of vitaminDreceptor binding sites defines the different vitamin D responsiveness of the CYP24 gene in malignant and normal mammary cells. J Biol Chem. 2010; 285: 24174-24183.
54. Kim MS, Fujiki R, Kitagawa H, Kato S. 1β, 25(OH)2D3-induced DNA methylation suppresses the human CYP27B1 gene. Mol Cell Endocrinol. 2007; 265-266: 168-173.
55. Ellfolk M, Norlin M, Gyllensten K, Wikvall K. Regulation of human vitamin D3 25-hydroxylases in dermal fibroblasts and prostate cancer LNCaP cells. Mol Pharmacol. 2009; 75: 1392-1399.
56. Kerner SA, Scott RA, Pike JW. Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3. Proc Natl Acad Sci USA. 1989; 86: 4455-4459.
57. Mahonen A, Jukkola A, Risteli L, Risteli J, Mäenpää PH. Type I procollagen synthesis is regulated by steroids and related hormones in human osteosarcoma cells. J Cell Biochem. 1998; 68: 151-163.
58. Fujisawa R, Tamura M. Acidic bone matrix proteins and their roles in calcification. Front Biosci (Landmark Ed). 2012; 17: 1891-1903.
59. Nemere I, Wilson C, Jensen W, Steinbeck M, Rohe B, Farach-Carson MC. Mechanism of 24, 25-dihydroxyvitamin D3-mediated inhibition of rapid, 1, 25-dihydroxyvitamin D3-induced responses: role of reactive oxygen species. J Cell Biochem. 2006; 99: 1572-1581.
60. Li XY, Boudjelal M, Xiao JH, et al. 1, 25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin. Mol Endocrinol. 1999; 13: 1686-1694.
61. Mizwicki MT, Norman AW. Two key proteins of the vitamin D endocrine system come into crystal clear focus: comparison of the X-ray structures of the nuclear receptor for 1β, 25(OH)2 vitamin D3, the plasma vitamin D binding protein, and their ligands. J Bone Miner Res. 2003; 18: 795-806.